Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants.
Shih-Han KoWan-Yu ChenShih-Chieh SuHsiu-Ting LinFeng-Yi KeKang-Hao LiangFu-Fei HsuMonika KumariChi-Yu FuHan-Chung WuPublished in: Journal of biomedical science (2022)
Since there are not many mAbs that can bind the S2 subunit of SARS-CoV-2 variants, our set of B-S2-mAbs may provide important materials for basic research and potential clinical applications. Importantly, our study results demonstrate that the viral S2 subunit can be targeted for the production of cross-reactive antibodies, which may be used for coronavirus detection and neutralization.